INNVIERTE | CDTI

INNVIERTE

CDTI Innovation’s SICC Innvierte invests in Aleos Fund I, a fund launched by Aleos Capital to support the growth of SMEs in the biosciences sector

The CDTI Innovation has committed an investment of 37.5 million euros in this fund

Innvierte allocates in February more than 50 million euros to 8 new co-investments in risk capital and 1 investment vehicle

These operations, carried out in EBTs, are aimed at developments in the Bio, Health and Agri-Food, Energy and Environment, ICT and Industry sectors.

The SICC Innvierte of the CDTI Innovation invests, together with BeAble Innvierte Kets Fund, in Molecular Gate, a company that develops an authentication technology to protect the labeling and packaging of products against counterfeiting

The contribution of the CDTI Innovation in this operation is 450,000 euros

CDTI Innovation’s SICC Innvierte invests together with Swanlaab Innvierte Agri Food Tech in Grodi, to accelerate digitisation and robotisation in greenhouses

The contribution of the CDTI Innovation in this operation is 500,000 euros

The SICC Innvierte of the CDTI Innovation invests in ABAC HORIZON FUND INNVIERTE, F.C.R, fund launched by ABAC CAPITAL to promote the generation of a positive environmental impact

The CDTI Innovation has committed an investment of up to 73.5 million euros in this fund

Innvierte allocates in January about 82 million euros to 7 new co-investments in risk capital and 1 investment vehicle

These operations, carried out in EBTs, are aimed at developments in the Bio, Health and Agri-Food, Energy and Environment, ICT and Industry sectors.

The SICC Innvierte of CDTI Innovation invests together with three co-investors, in BLUE-BOOST, S.L., a company that develops a market intelligence platform to search for investment opportunities.

The CDTI Innovation has closed an investment of 405,270 euros in this company, which adds a total of 2,205,270 euros committed

The SICC Innvierte of the CDTI Innovation invests in KEMBARA FUND I, F.C.R, fund launched by Mundi Ventures of 1 billion euros, to support Deep Tech and climate startups in Europe

The CDTI Innovation has committed an investment of up to 300 million euros in this fund

The SICC Innvierte of CDTI Innovation invests together with several co-investors in Orikine Bio, a company that develops a new generation of therapies for autoimmune, inflammatory and oncological diseases

The CDTI Innovation has committed an investment of 2.7 million euros in this company

Subscribe to INNVIERTE